Overview
No overview information available.
Background
No background information available.
Indication
联合盐酸安罗替尼胶囊、卡铂和依托泊苷用于广泛期小细胞肺癌(ES-SCLC)的一线治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2025/05/28 | Phase 2 | Recruiting | |||
2025/05/02 | Phase 3 | Not yet recruiting | The First Affiliated Hospital of Guangzhou Medical University | ||
2025/04/17 | Phase 4 | Not yet recruiting | |||
2024/12/13 | Phase 2 | Recruiting | Sun Yat-sen University | ||
2024/11/21 | Phase 2 | Not yet recruiting | |||
2024/09/19 | Not Applicable | Not yet recruiting | Xijing Hospital | ||
2024/07/30 | Phase 2 | Recruiting | Shanghai Pulmonary Hospital, Shanghai, China | ||
2024/01/25 | Phase 2 | Not yet recruiting | Peking University | ||
2023/10/31 | Phase 2 | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | ||
2023/02/08 | Phase 3 | Not yet recruiting |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
Benmelstobart Injection | 国药准字S20240017 | 生物制品 | 注射剂 | 4/30/2024 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |